Molecular markers of fragile X: clinical aspects of carrier detection and prenatal diagnosis.
Patricia D. Murphy(Newark Beth Israel Medical Center), L. R. Shapiro(New York Medical College), P L Wilmot
PubMed
January 1, 1991
Cited by 0
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Genetic Information and the Workplace: Legislative Approaches and Policy Challenges
|Science|1997|153
Human genome agreements.
|PubMed|1997|69